Macrophage Secretory Function among Urinary Tract Infection Patients before and after Ciprofloxacin Treatment: A Prospective Study
Abstract
Background: Attacks of Urinary tract infections (UTIs) reached about 150 million patients every year worldwide. They are considered a major reason for morbidity in females in all age groups, older men and young boys. Objectives: To investigate the effect of Ciprofloxacin treatment during urinary tract infection (UTI) infection on the proinflammatory cytokines secretion including IL-1, IL-6, IL-10, IL-12, and TNF in the adult patients. Methodology: This prospective, observational cohort study involved 50 patients diagnosed with UTI over a period of 3 months from January to March 2019. On the day of admission (before starting ciprofloxacin treatment), all the UTI patients were submitted to an estimation of urine levels of proinflammatory cytokines including IL-1, IL-6, IL-12, IL-10, and TNF during the first 48 hours after hospital admission. Cytokine levels were estimated by enzyme-linked immunoassay (ELISA) kits (R&D Systems, Inc., Minneapolis, Minnesota, USA). The patients were treated with ciprofloxacin 500mg for 3 days. After 5 days of ciprofloxacin treatment course, the patient underwent remeasurement of urine level of cytokines. Results: After the fifth day of ciprofloxacin treatment course, it has been observed that there were significant decreases regarding proinflammatory cytokine TNF, IL1, and IL6. On the other hand, there was a significant increase in IL10 levels in the study cohort. Besides, there was no significant difference between before and after ciprofloxacin…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 150 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.